James A Mcnulty Inhibitor Therapeutics, Inc. (INTI) insider trading activity

INTI Quotes by TradingView

James A Mcnulty is CHIEF FINANCIAL OFFICER of Inhibitor Therapeutics, Inc.. Currently has a direct ownership of 946,135 shares of INTI, which is worth approximately $75,690. The most recent transaction as insider was on May 05, 2023, when has been sold 398,135 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 946K
0% 3M change
0% 12M change
Total Value Held $75,690

JAMES A MCNULTY Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 05 2023
BUY
Other acquisition or disposition
-
398,135 Added 29.62%
946,135 Common Stock

Also insider at

ENOB
Enochian Biosciences Inc Healthcare
Director
JAM

James A Mcnulty

CHIEF FINANCIAL OFFICER
Tampa, FL

Track Institutional and Insider Activities on INTI

Follow Inhibitor Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INTI shares.

Notify only if

Insider Trading

Get notified when an Inhibitor Therapeutics, Inc. insider buys or sells INTI shares.

Notify only if

News

Receive news related to Inhibitor Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on INTI